This NDA submission is an important milestone, and it brings gedatolisib one step closer to becoming available for patients with HR+/HER2- advanced breast cancer,” said Brian Sullivan, CEO and ...
The High Court has ordered the Inspector-General of Police to execute a warrant of arrest against Defence Principal Secretary ...
FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) ...
Union Home Minister Amit Shah on Monday (November 3, 2025) said a defence corridor will come up in Bihar and factories will be set up in each district if the NDA is voted to power. Bihar Assembly ...
Union Home Minister Amit Shah has said they are "fighting under Nitish Kumar's leadership" Amit Shah has credited Nitish Kumar's leadership for improved law and order in Bihar NDA is highlighting ...
(MENAFN- IANS) New Delhi, Nov 2 (IANS) As the countdown to the 2025 Bihar Assembly elections picks up pace, leaders of the ruling alliance have launched a full-throated campaign of confidence, ...
Patna (Bihar) [India], October 24 (ANI): Ahead of Prime Minister Narendra Modi's visit to Bihar, state BJP president Dilip Jaiswal on Friday exuded confidence that the NDA will win the assembly ...
Jaipur, (Rajasthan) [India], October 21 (ANI): Rajasthan Deputy Chief Minister Diya Kumari on Tuesday expressed confidence in the NDA's success in the upcoming Bihar election. After participating in ...
TAIPEI, Oct. 1, 2025 /PRNewswire/ -- TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...
The MarketWatch News Department was not involved in the creation of this content. TAIPEI, Oct. 1, 2025 /CNW/ -- TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug ...
BROSSARD, Que. — Training camp is a good time to experiment with different combinations to see what works and what doesn’t. However, Montreal Canadiens coach Martin St. Louis does not sound like ...
MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results